Shaw Pharmaceuticals Pvt Ltd - Due diligence report

A 360° intelligence report on Shaw Pharmaceuticals Pvt Ltd: trust score, financial health, credit view, compliance, directors, growth and di…

2005-11-25 Kolkata, West Bengal Active Unlisted Active Compliant
Share
Connect MCP
SP Shaw Pharmaceuticals Pvt Ltd
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Shaw Pharmaceuticals Pvt Ltd — 360° Intelligence Report

Generated from MCA filings & public records
49/100
Trust Score
Caution Indicated

Shaw Pharmaceuticals Pvt Ltd is assessed as Caution Indicated with a Trust Score of 49/100. Shaw Pharmaceuticals Pvt Ltd is an active private limited indian non-government company incorporated in 2005, operating in the Healthcare sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and high financial risk profile.

Report generated on 01 Oct 2026 from the latest processed filings. Shaw Pharmaceuticals Pvt Ltd snapshot & full profile →

Financial Health › Weak
Overall Assessment CautionWeakNeutralGoodStrong Neutral
Compliance › Weak

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreCaution Indicated
49/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
38/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
30/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
40/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
50/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 3 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 40/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Elevated gearing (D/E 38%).
  • Working-capital cover adequate.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 38/100 Caution Indicated
  • Company status is Active as per MCA.
  • Last balance sheet is for Mar 2020 - filings overdue.
  • Flagged by authority: MCA.
  • Litigation present in 1 court forum(s).
  • 1 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
BANKIM CHANDRA SHAW 01234567 Director 01/04/2018 6 yrs Approved
CHANDRA SHEKHAR SHAW 01234567 Director 01/04/2018 6 yrs Approved
ASHISH SHAW 01234567 Director 01/04/2018 6 yrs Approved
NARENDRA NATH SHAW 01234567 Director 01/04/2018 6 yrs Approved
SANJAY SHAW 01234567 Director 01/04/2018 6 yrs Approved
  • 5 directors on the board.
  • BANKIM CHANDRA SHAW has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2017)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2017 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a majority stake - exact percentages are part of the full report.

Key managerial personnel: BANKIM CHANDRA SHAW (Managing Director) · CHANDRA SHEKHAR SHAW (Whole-time director) · ASHISH SHAW (Whole-time director) · NARENDRA NATH SHAW (Whole-time director) · SANJAY SHAW (Whole-time director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 40 · Distress 50
Growth signals & trust indicators
Operating for 20+ years.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
Statutory filings appear overdue.
Compliance score is weak (38/100).
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence45/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 3 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment36/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view39/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 9 events
31 Dec 2020
Last AGM held
Annual general meeting
31 Mar 2020
Latest balance sheet
Filed with ROC
02 Jun 2011
Director ceased
PANKAJ KUMAR SHAW
25 Nov 2005
Incorporated
Registered with Roc Kolkata
Director appointed
BANKIM CHANDRA SHAW (Managing Director)
Director appointed
CHANDRA SHEKHAR SHAW (Whole-time director)
Director appointed
ASHISH SHAW (Whole-time director)
Director appointed
NARENDRA NATH SHAW (Whole-time director)
Director appointed
SANJAY SHAW (Whole-time director)
10

Key Observations

Auto-generated from the data above
Revenue declined 1.42 over the last 2 financial year(s).
Net profit margin moved from 2.1x to 24%.
Debt-to-equity stands at 0.86 - leverage worth monitoring.
Net worth is positive.
5 active director(s) / partner(s); review board churn before relying on management continuity.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a majority stake as per the FY 2017 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Veevon Healthcare Private Limited U51397DL2015PTC288742 Delhi, Delhi, India
Blissful Health Services Private Limited U24232DL2005PTC135776 New Delhi, Delhi, India
Fit-Life Fitness Private Limited U85100HR2012PTC047665 Gurgaon, Haryana, India
Metagrafi Services Private Limited U72400KA1999PTC025577 Banglore, Karnataka, India
Cordial Health Service Private Limited U74999TG2016PTC110642 Hyderabad, Telangana, India
Sukritim Charitable Foundation U85191MH2011NPL222213 Mumbai, Maharashtra, India
Viola Scribe Medical Transcription Private Limited U74140OR2016PTC020011 Baripada, Orissa, India
Aakash Agro Health And Hospitality Private Limited U74999JK2011PTC003433 Kud, Jammu & Kashmir, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Shaw Pharmaceuticals Pvt Ltd before audits and certifications: compliance score 38/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Shaw Pharmaceuticals Pvt Ltd: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 40/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score 40/100, margin trends, ownership structure and peer set for Shaw Pharmaceuticals Pvt Ltd - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 49/100, distress signals and MSME payment-delay disclosures - know whether Shaw Pharmaceuticals Pvt Ltd pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Shaw Pharmaceuticals Pvt Ltd - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Shaw Pharmaceuticals Pvt Ltd an active company?

Shaw Pharmaceuticals Pvt Ltd has MCA status “Active” with a compliance score of 38/100 (Caution Indicated).

Is Shaw Pharmaceuticals Pvt Ltd financially healthy?

Shaw Pharmaceuticals Pvt Ltd has a Financial Health Score of 30/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Shaw Pharmaceuticals Pvt Ltd?

Its overall Trust Score is 49/100 (Caution Indicated). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Shaw Pharmaceuticals Pvt Ltd?

Promoters hold a majority stake - exact percentages are in the full report. 5 active director(s) are on record.

Does Shaw Pharmaceuticals Pvt Ltd have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Shaw Pharmaceuticals Pvt Ltd up to date with its ROC filings?

Last balance sheet is for Mar 2020 - filings overdue. Overall compliance score: 38/100 (Caution Indicated).

Is it risky to lend to Shaw Pharmaceuticals Pvt Ltd?

Its Credit Risk Score is 40/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.